Quality of life in patients with TIA and minor ischemic stroke
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received February 25, 2015
- Accepted in final form June 29, 2015
- First Published November 4, 2015.
Article Versions
- Previous version (November 4, 2015 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Rajbeer S. Sangha, MD,
- Fan Z. Caprio, MD,
- Robert Askew, PhD, MPH,
- Carlos Corado, MS,
- Richard Bernstein, MD, PhD,
- Yvonne Curran, MD,
- Ilana Ruff, MD,
- David Cella, PhD,
- Andrew M. Naidech, MD, MSPH and
- Shyam Prabhakaran, MD
- Rajbeer S. Sangha, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Fan Z. Caprio, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Robert Askew, PhD, MPH,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Carlos Corado, MS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Richard Bernstein, MD, PhD,
Scientific advisory boards for Boehringer Ingelheim, Pfizer, Bristol Myers, Medtronic.
NONE
Speaker fees from Boehringer Ingelheim, Medtronic, Pfizer, Bristol Meyers
NONE
NONE
NONE
NONE
NONE
Boehringer INgelheim, Pfizer, Bristol Myers, Medtronic
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Expert witness consultant for plaintiff and defense related to stroke.
- Yvonne Curran, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ilana Ruff, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- David Cella, PhD,
Moffitt Scientific Advisory Board NCI Symptom Management and Health-Related Quality of Life (SxQOL) Steering Committee
NONE
Travel funds to attend advisory board and/or consulting meetings: Bayer, BMS, Clovis, GSK, Helsinn
Journal of Supportive Oncology, Associate Editor
NONE
Up to Date Annual Review: Quality of Life Measures
NONE
Pfizer Genetech Novartis Bayer GlaxoSmith Kline
NONE
NONE
NONE
Pfizer Genentech Novartis Bayer GlaxoSmith Kline Aveo
National Institutes of Health PROMIS: 1U5AR057951-01 NeuroQOL:HHSN 265200436 Toolbox: AG-260-06-01 PROsetta Stone: 1RC4CA157236-01 SyMON: CA60068
NONE
NONE
President: FACIT.org
NONE
President: FACIT.org
President: FACIT.org
NONE
NONE
- Andrew M. Naidech, MD, MSPH and
NONE
NONE
Korean Society of Critical Care Medicine paid costs for travel to and from board review course 2012 in Seoul, South Korea, where I served as faculty. Travel and compensation to give grand rounds at the U of Massachusetts in 2013 and University of Wisconsin-Madison in 2014.
Editorial board, Neurocritical Care, uncompensated
NONE
Bendok, Batjer, Naidech, Walker, eds. Ischemic hemorrhagic stroke. Thieme, New York, 2011.
NONE
NONE
NONE
NONE
NONE
NONE
Neuro-QOL: Interim Sustainability and Training Contract number: HHSN271201200036C. 5% salary support (Co-I) for extending the use of Neuro-QOL in clinical research (PI: David Cella)
NONE
Northwestern Memorial Foundation for
NONE
NONE
NONE
NONE
NONE
NONE
- Shyam Prabhakaran, MD
NONE
NONE
NONE
Current Atherosclerosis Reports; Section editor; 2014-2015
NONE
Cryptogenic stroke, Uptodate, 2006-current
NONE
NONE
NONE
NONE
NONE
NONE
NINDS: NS084288-01A1 (3/2014-present; PI); 1U10NS086608- 01 (10/2013-present, PI) PCORI: AD-1310-07237 (10/2014-present, PI)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Departments of Neurology (R.S.S., F.Z.C., C.C., R.B., Y.C., I.R., A.M.N., S.P.) and Medical Social Sciences (R.A., D.C.), Northwestern University Feinberg School of Medicine, Chicago, IL.
- Correspondence to Dr. Prabhakaran: sprabhak{at}nm.org
Article usage
Cited By...
Letters: Rapid online correspondence
- Reply to "Actual impairment or subjective disability"
- Shyam Prabhakaran, sprabhak@nm.org
Submitted January 14, 2016 - Actual impairment or subjective disability
- Sameer Sharma, Stroke fellow, Upstate university hospitalSameersharma12@gmail.com
Submitted January 12, 2016
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan